Cargando…

Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland

SUMMARY: Hypovitaminosis D is a problem among hip fracture patients. In a 1-year cohort study comprising 245 hip fracture patients (mean age of females 81 years and males 78 years) from south-eastern Finland, the mean 25-hydroxyvitamin D [S-25(OH)D] concentration was 73(SD 31) nmol/L. Vitamin D supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmi-Lüthje, I., Tiihonen, R., Paattiniemi, E.-L., Naboulsi, H., Pigg, S., Sarkkinen, H., Kaukonen, J.-P., Toivanen, A., Salmio, K., Kataja, M., Lüthje, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854727/
https://www.ncbi.nlm.nih.gov/pubmed/29260288
http://dx.doi.org/10.1007/s00198-017-4344-1
_version_ 1783306963420971008
author Nurmi-Lüthje, I.
Tiihonen, R.
Paattiniemi, E.-L.
Naboulsi, H.
Pigg, S.
Sarkkinen, H.
Kaukonen, J.-P.
Toivanen, A.
Salmio, K.
Kataja, M.
Lüthje, P.
author_facet Nurmi-Lüthje, I.
Tiihonen, R.
Paattiniemi, E.-L.
Naboulsi, H.
Pigg, S.
Sarkkinen, H.
Kaukonen, J.-P.
Toivanen, A.
Salmio, K.
Kataja, M.
Lüthje, P.
author_sort Nurmi-Lüthje, I.
collection PubMed
description SUMMARY: Hypovitaminosis D is a problem among hip fracture patients. In a 1-year cohort study comprising 245 hip fracture patients (mean age of females 81 years and males 78 years) from south-eastern Finland, the mean 25-hydroxyvitamin D [S-25(OH)D] concentration was 73(SD 31) nmol/L. Vitamin D supplementation has been integrated into our current practice. INTRODUCTION: The objectives of this study are to verify vitamin D levels among hip fracture patients and to compare the results with a similar study conducted in the same two hospitals covering the same geographic area 12 years ago. METHODS: A prospective cohort comprising 245 Caucasian hip fracture patients was enrolled in the study in two acute hospitals in south-eastern Finland (61° N) over a 12-month period in 2015–2016. The S-25(OH)D was measured using 25-hydroxyvitamin D electrochemiluminescence binding assay. The S-25(OH)D concentrations were compared with the corresponding concentrations of a similar cohort analyzed in the same two hospitals 12 years ago. RESULTS: Of the 245 patients, 70% were women with a mean age of 81 (SD 10) years, while the men had a mean age of 78 (SD 12) years (p < 0.01). The total mean S-25(OH)D concentration was 73 (SD 31.3) nmol/L. Regional differences were found: 15% in hospital A and 36% in hospital B had a S-25(OH(D level < 50 nmol/L, and the mean S-25(OH)D level was 79.2 (SD 31.7) nmol/L in hospital A and 62.4 (SD 27.5) nmol/L in hospital B (p < 0.001). No differences were found in S-25(OH)D concentrations by either the place of residence or the time of year. Overall, the percentage of patients with a sufficient vitamin D level (> 50 nmol/L) was remarkably higher in 2015–2016 (77%) than in 2003–2004 (22%). CONCLUSION: Our results indicate that vitamin D supplementation has been widely integrated into our current practice. However, regional differences were found in the S-25(OH)D concentrations for which the reasons are unknown.
format Online
Article
Text
id pubmed-5854727
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-58547272018-03-22 Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland Nurmi-Lüthje, I. Tiihonen, R. Paattiniemi, E.-L. Naboulsi, H. Pigg, S. Sarkkinen, H. Kaukonen, J.-P. Toivanen, A. Salmio, K. Kataja, M. Lüthje, P. Osteoporos Int Original Article SUMMARY: Hypovitaminosis D is a problem among hip fracture patients. In a 1-year cohort study comprising 245 hip fracture patients (mean age of females 81 years and males 78 years) from south-eastern Finland, the mean 25-hydroxyvitamin D [S-25(OH)D] concentration was 73(SD 31) nmol/L. Vitamin D supplementation has been integrated into our current practice. INTRODUCTION: The objectives of this study are to verify vitamin D levels among hip fracture patients and to compare the results with a similar study conducted in the same two hospitals covering the same geographic area 12 years ago. METHODS: A prospective cohort comprising 245 Caucasian hip fracture patients was enrolled in the study in two acute hospitals in south-eastern Finland (61° N) over a 12-month period in 2015–2016. The S-25(OH)D was measured using 25-hydroxyvitamin D electrochemiluminescence binding assay. The S-25(OH)D concentrations were compared with the corresponding concentrations of a similar cohort analyzed in the same two hospitals 12 years ago. RESULTS: Of the 245 patients, 70% were women with a mean age of 81 (SD 10) years, while the men had a mean age of 78 (SD 12) years (p < 0.01). The total mean S-25(OH)D concentration was 73 (SD 31.3) nmol/L. Regional differences were found: 15% in hospital A and 36% in hospital B had a S-25(OH(D level < 50 nmol/L, and the mean S-25(OH)D level was 79.2 (SD 31.7) nmol/L in hospital A and 62.4 (SD 27.5) nmol/L in hospital B (p < 0.001). No differences were found in S-25(OH)D concentrations by either the place of residence or the time of year. Overall, the percentage of patients with a sufficient vitamin D level (> 50 nmol/L) was remarkably higher in 2015–2016 (77%) than in 2003–2004 (22%). CONCLUSION: Our results indicate that vitamin D supplementation has been widely integrated into our current practice. However, regional differences were found in the S-25(OH)D concentrations for which the reasons are unknown. Springer London 2017-12-19 2018 /pmc/articles/PMC5854727/ /pubmed/29260288 http://dx.doi.org/10.1007/s00198-017-4344-1 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Nurmi-Lüthje, I.
Tiihonen, R.
Paattiniemi, E.-L.
Naboulsi, H.
Pigg, S.
Sarkkinen, H.
Kaukonen, J.-P.
Toivanen, A.
Salmio, K.
Kataja, M.
Lüthje, P.
Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
title Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
title_full Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
title_fullStr Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
title_full_unstemmed Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
title_short Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland
title_sort remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in south-eastern finland
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854727/
https://www.ncbi.nlm.nih.gov/pubmed/29260288
http://dx.doi.org/10.1007/s00198-017-4344-1
work_keys_str_mv AT nurmiluthjei remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT tiihonenr remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT paattiniemiel remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT naboulsih remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT piggs remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT sarkkinenh remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT kaukonenjp remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT toivanena remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT salmiok remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT katajam remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland
AT luthjep remarkableimprovementinserum25hydroxyvitaminlevelsamonghipfracturepatientsovera12yearperiodaprospectivestudyinsoutheasternfinland